HALOZYME THERAP
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for HALOZYME THERAP NOTE 0.250% 3/0, CUSIP 40637had1.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for HALOZYME THERAP NOTE 0.250% 3/0, CUSIP 40637had1.